Found: 25
Select item for more details and to access through your institution.
Treating stage I nonseminomatous germ cell tumours with a single cycle of chemotherapy.
- Published in:
- BJU International, 2006, v. 98, n. 1, p. 67, doi. 10.1111/j.1464-410X.2006.06188.x
- By:
- Publication type:
- Article
IGF1R signalling in testicular germ cell tumour cells impacts on cell survival and acquired cisplatin resistance.
- Published in:
- Journal of Pathology, 2018, v. 244, n. 2, p. 242, doi. 10.1002/path.5008
- By:
- Publication type:
- Article
T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1296948
- By:
- Publication type:
- Article
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
- Published in:
- JNCI Cancer Spectrum, 2022, v. 6, n. 4, p. 1, doi. 10.1093/jncics/pkac043
- By:
- Publication type:
- Article
Understanding the molecular biology of anal squamous cell carcinoma.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 3, p. 410, doi. 10.1002/ijc.34782
- By:
- Publication type:
- Article
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
- Published in:
- PLoS Medicine, 2022, v. 19, n. 6, p. 1, doi. 10.1371/journal.pmed.1003998
- By:
- Publication type:
- Article
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Accessing routinely collected health data to improve clinical trials: recent experience of access.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Reply to Comments on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis".
- Published in:
- 2019
- By:
- Publication type:
- Letter
Reply to Comments on "Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis".
- Published in:
- 2019
- By:
- Publication type:
- Letter
Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy.
- Published in:
- 2018
- By:
- Publication type:
- corrected article
No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Biomarkers in anal cancer: from biological understanding to stratified treatment.
- Published in:
- British Journal of Cancer, 2017, v. 116, n. 2, p. 156, doi. 10.1038/bjc.2016.398
- By:
- Publication type:
- Article
Biomarkers in anal cancer: from biological understanding to stratified treatment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Transdermal oestradiol as a method of androgen suppression for prostate cancer within the STAMPEDE trial platform.
- Published in:
- BJU International, 2018, v. 121, n. 5, p. 680, doi. 10.1111/bju.14153
- By:
- Publication type:
- Article
Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones ( PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer.
- Published in:
- BJU International, 2017, v. 119, n. 5, p. 667, doi. 10.1111/bju.13687
- By:
- Publication type:
- Article
Increased risk of HPV‐associated genital cancers in men and women as a consequence of pre‐invasive disease.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 2, p. 427, doi. 10.1002/ijc.32126
- By:
- Publication type:
- Article
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 3, p. 515, doi. 10.1038/s41416-024-02756-x
- By:
- Publication type:
- Article
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 4, p. 706, doi. 10.1038/s41416-023-02310-1
- By:
- Publication type:
- Article
Minimum regions of genomic imbalance in stage I testicular embryonal carcinoma and association of 22q loss with relapse.
- Published in:
- Genes, Chromosomes & Cancer, 2011, v. 50, n. 3, p. 186, doi. 10.1002/gcc.20843
- By:
- Publication type:
- Article
Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations.
- Published in:
- Journal of Pathology: Clinical Research, 2022, v. 8, n. 1, p. 3, doi. 10.1002/cjp2.246
- By:
- Publication type:
- Article
Next Generation Sequencing Assay for Detection of Circulating HPV DNA (cHPV-DNA) in Patients Undergoing Radical (Chemo)Radiotherapy in Anal Squamous Cell Carcinoma (ASCC).
- Published in:
- Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00505
- By:
- Publication type:
- Article
A comparison of different population-level summary measures for randomised trials with time-to-event outcomes, with a focus on non-inferiority trials.
- Published in:
- Clinical Trials, 2023, v. 20, n. 6, p. 594, doi. 10.1177/17407745231181907
- By:
- Publication type:
- Article